GRANITERO INJECTION 3MG

Granitero 3mg injection is classified as a member of the 5-HT3 receptor antagonists or antiemetics. It contains Granisetron as its active ingredient. This medication is utilized to prevent and manage nausea, vomiting, or sickness that may occur due to cancer therapies such as chemotherapy, radiotherapy, or post-surgery. Nausea is typically associated with stomach discomfort and the sensation of needing to vomit. The act of forcefully expelling the stomach’s contents through the mouth is referred to as vomiting.

Common side effects associated with Granitero 3mg injection include headaches, constipation, diarrhea, insomnia, and alterations in liver function. These side effects may not affect everyone and can vary from person to person. If these side effects are bothersome or persist, please inform your physician.

If you experience any allergic reactions to Granitero 3mg or its components, report this to your doctor. Additionally, notify your physician if you have any issues with bowel movements or heart conditions prior to commencing treatment with Granitero 3mg injection. Serotonin syndrome is a rare yet serious complication that may occur when this medication is combined with certain other drugs (such as duloxetine, fluvoxamine, etc.). It is important to discuss your current medications with your doctor before starting treatment with Granitero 3mg injection. This medication is recommended for use by pregnant and breastfeeding women.